Page last updated: 2024-10-24

positive regulation of osteoclast proliferation

Definition

Target type: biologicalprocess

Any process that increases the rate, frequency, or extent of the multiplication or reproduction of osteoclasts, resulting in the expansion of an osteoclast cell population. [GOC:tb]

Positive regulation of osteoclast proliferation is a complex process that involves a tightly regulated interplay of signaling pathways, transcription factors, and cytokines. It is essential for maintaining bone homeostasis by balancing bone resorption and formation. Osteoclasts are multinucleated cells responsible for bone resorption. Their proliferation is regulated by a variety of factors, including RANKL (receptor activator of nuclear factor κB ligand), M-CSF (macrophage colony-stimulating factor), and various cytokines.

RANKL, a type II transmembrane protein expressed on osteoblasts and stromal cells, binds to its receptor RANK (receptor activator of nuclear factor κB) on osteoclast precursors. This interaction triggers downstream signaling pathways, including the NF-κB, MAPK, and PI3K pathways. Activation of these pathways promotes osteoclast differentiation, survival, and proliferation.

M-CSF, a hematopoietic growth factor, binds to its receptor c-Fms on osteoclast precursors. This interaction stimulates osteoclast proliferation and survival.

In addition to RANKL and M-CSF, several other cytokines, including TNF-α, IL-1, and IL-6, can also stimulate osteoclast proliferation. These cytokines activate signaling pathways that promote osteoclast differentiation and survival.

The regulation of osteoclast proliferation is tightly controlled by a balance of stimulatory and inhibitory factors. Osteoprotegerin (OPG), a soluble decoy receptor for RANKL, inhibits RANKL signaling and thereby prevents osteoclast formation.

Furthermore, the Wnt signaling pathway plays a crucial role in regulating osteoclast proliferation. Activation of the Wnt pathway inhibits osteoclast formation and activity.

In summary, positive regulation of osteoclast proliferation involves a complex network of signaling pathways, transcription factors, and cytokines. This process is tightly regulated to maintain bone homeostasis and prevent excessive bone resorption.'
"

Proteins (1)

ProteinDefinitionTaxonomy
Neuromedin-B receptorA neuromedin-B receptor that is encoded in the genome of human. [PRO:WCB, UniProtKB:P28336]Homo sapiens (human)

Compounds (6)

CompoundDefinitionClassesRoles
harmalanharmalan: structure given in first sourceharmala alkaloid
1-methyl-6-methoxy-dihydro-beta-carboline
harmineharmine : A harmala alkaloid in which the harman skeleton is methoxy-substituted at C-7.

Harmine: Alkaloid isolated from seeds of PEGANUM HARMALA; ZYGOPHYLLACEAE. It is identical to banisterine, or telepathine, from Banisteria caapi and is one of the active ingredients of hallucinogenic drinks made in the western Amazon region from related plants. It has no therapeutic use, but (as banisterine) was hailed as a cure for postencephalitic PARKINSON DISEASE in the 1920's.
harmala alkaloidanti-HIV agent;
EC 1.4.3.4 (monoamine oxidase) inhibitor;
metabolite
pd 176252PD 176252: a non-peptide gastrin-releasing peptide (BB2) receptor antagonist; structure in first source
pd 168368PD 168368: a neuromedin B receptor antagonist; structure in first source
bombesin